FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3193709867> ?p ?o ?g. }

• W3193709867 endingPage "78" @default.
• W3193709867 startingPage "72" @default.
• W3193709867 abstract "Hormonal therapies are commonly prescribed to patients with metastatic granulosa cell tumours (GCT), based on high response rates in small retrospective studies. Aromatase inhibitors (AIs) are reported to have high response rates and an accepted treatment option. We report the results of a phase 2 trial of an AI in recurrent/metastatic GCTs.41 patients with recurrent ER/PR + ve GCT received anastrozole 1 mg daily until progression or unacceptable toxicity. The primary endpoint was clinical benefit rate (CBR) at 12 weeks, evaluated by RECIST1.1 criteria. Secondary endpoints included progression-free survival (PFS), CBR duration, quality of life and toxicity.The CBR at 12 weeks in 38 evaluable patients was 78.9%, which included one (2.6%; 95% CI: 0.5-13.5%) partial response and 76.3% stable disease. Two additional patients without measurable disease were stable, based on inhibin. Median PFS was 8.6 m (95% CI 5.5-13.5 m). There were delayed responses observed after 12 weeks with a total of 4 pts. (10.5%; 95% CI 4.2%-24.1%) with a RECIST partial response; 23 (59%) patients were progression-free at 6 months. The adverse effects were predominantly low grade.This is the first prospective trial of hormonal therapy in GCTs. Although there was a high CBR, the objective response rate to anastrozole was much lower than the pooled response rates of >70% to AIs reported in most retrospective series and case reports. PARAGON demonstrates the importance of prospective trials in rare cancers and the need to reconsider the role of AIs as single agents in GCTs." @default.
• W3193709867 created "2021-08-30" @default.
• W3193709867 creator A5001026176 @default.
• W3193709867 creator A5003079638 @default.
• W3193709867 creator A5007752071 @default.
• W3193709867 creator A5008590899 @default.
• W3193709867 creator A5009351129 @default.
• W3193709867 creator A5011119212 @default.
• W3193709867 creator A5012713019 @default.
• W3193709867 creator A5016742379 @default.
• W3193709867 creator A5018660654 @default.
• W3193709867 creator A5018801649 @default.
• W3193709867 creator A5021894535 @default.
• W3193709867 creator A5032801379 @default.
• W3193709867 creator A5038850730 @default.
• W3193709867 creator A5051483869 @default.
• W3193709867 creator A5051689511 @default.
• W3193709867 creator A5056093407 @default.
• W3193709867 creator A5056772784 @default.
• W3193709867 creator A5058371392 @default.
• W3193709867 creator A5065447416 @default.
• W3193709867 creator A5068472422 @default.
• W3193709867 creator A5071781603 @default.
• W3193709867 creator A5080422321 @default.
• W3193709867 creator A5089788519 @default.
• W3193709867 date "2021-10-01" @default.
• W3193709867 modified "2023-10-14" @default.
• W3193709867 title "A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trial" @default.
• W3193709867 cites W1515288906 @default.
• W3193709867 cites W1977836596 @default.
• W3193709867 cites W1987880828 @default.
• W3193709867 cites W1993222497 @default.
• W3193709867 cites W1995818546 @default.
• W3193709867 cites W2000775791 @default.
• W3193709867 cites W2005860883 @default.
• W3193709867 cites W2007801121 @default.
• W3193709867 cites W2018397776 @default.
• W3193709867 cites W2020018978 @default.
• W3193709867 cites W2028221132 @default.
• W3193709867 cites W2048649793 @default.
• W3193709867 cites W2050375520 @default.
• W3193709867 cites W2059319812 @default.
• W3193709867 cites W2066801022 @default.
• W3193709867 cites W2068045700 @default.
• W3193709867 cites W2071460680 @default.
• W3193709867 cites W2126900445 @default.
• W3193709867 cites W2135153712 @default.
• W3193709867 cites W2137631399 @default.
• W3193709867 cites W2139699375 @default.
• W3193709867 cites W2238796990 @default.
• W3193709867 cites W2270513396 @default.
• W3193709867 cites W2324428505 @default.
• W3193709867 cites W2803594602 @default.
• W3193709867 cites W2896140591 @default.
• W3193709867 cites W2914373213 @default.
• W3193709867 cites W3012417669 @default.
• W3193709867 cites W3031129122 @default.
• W3193709867 cites W3092371828 @default.
• W3193709867 doi "https://doi.org/10.1016/j.ygyno.2021.07.024" @default.
• W3193709867 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34412908" @default.
• W3193709867 hasPublicationYear "2021" @default.
• W3193709867 type Work @default.
• W3193709867 sameAs 3193709867 @default.
• W3193709867 citedByCount "15" @default.
• W3193709867 countsByYear W31937098672021 @default.
• W3193709867 countsByYear W31937098672022 @default.
• W3193709867 countsByYear W31937098672023 @default.
• W3193709867 crossrefType "journal-article" @default.
• W3193709867 hasAuthorship W3193709867A5001026176 @default.
• W3193709867 hasAuthorship W3193709867A5003079638 @default.
• W3193709867 hasAuthorship W3193709867A5007752071 @default.
• W3193709867 hasAuthorship W3193709867A5008590899 @default.
• W3193709867 hasAuthorship W3193709867A5009351129 @default.
• W3193709867 hasAuthorship W3193709867A5011119212 @default.
• W3193709867 hasAuthorship W3193709867A5012713019 @default.
• W3193709867 hasAuthorship W3193709867A5016742379 @default.
• W3193709867 hasAuthorship W3193709867A5018660654 @default.
• W3193709867 hasAuthorship W3193709867A5018801649 @default.
• W3193709867 hasAuthorship W3193709867A5021894535 @default.
• W3193709867 hasAuthorship W3193709867A5032801379 @default.
• W3193709867 hasAuthorship W3193709867A5038850730 @default.
• W3193709867 hasAuthorship W3193709867A5051483869 @default.
• W3193709867 hasAuthorship W3193709867A5051689511 @default.
• W3193709867 hasAuthorship W3193709867A5056093407 @default.
• W3193709867 hasAuthorship W3193709867A5056772784 @default.
• W3193709867 hasAuthorship W3193709867A5058371392 @default.
• W3193709867 hasAuthorship W3193709867A5065447416 @default.
• W3193709867 hasAuthorship W3193709867A5068472422 @default.
• W3193709867 hasAuthorship W3193709867A5071781603 @default.
• W3193709867 hasAuthorship W3193709867A5080422321 @default.
• W3193709867 hasAuthorship W3193709867A5089788519 @default.
• W3193709867 hasConcept C121608353 @default.
• W3193709867 hasConcept C126322002 @default.
• W3193709867 hasConcept C143998085 @default.
• W3193709867 hasConcept C197934379 @default.
• W3193709867 hasConcept C203092338 @default.
• W3193709867 hasConcept C2776166826 @default.
• W3193709867 hasConcept C2776215463 @default.

• next